Protocol for inducing cutaneous squamous cell carcinoma with chronic UV and treating with 5-aminolevulinic acid photodynamic therapy in SKH-1 mice. [PDF]
Zhou W +9 more
europepmc +1 more source
6-Aminonicotinamide enhances the efficacy of 5-aminolevulinic acid-mediated photodynamic therapy for neuroblastoma. [PDF]
Okamura SM +6 more
europepmc +1 more source
Effect of extending the oral administration period of 5-aminolevulinic acid on diagnostic accuracy and treatment outcomes for non-muscle-invasive bladder cancer. [PDF]
Fukuhara H +6 more
europepmc +1 more source
A phase III double-blind, placebo-controlled, randomized withdrawal trial of 5‑aminolevulinic acid hydrochloride with sodium ferrous citrate for efficacy and safety in patients diagnosed as Leigh syndrome. [PDF]
Ohtake A +22 more
europepmc +1 more source
Blood Pressure Changes After Oral 5-Aminolevulinic Acid Hydrochloride Administered 4-8 h Before TURBT: An Additional Analysis of a Phase III Study (SPP2C102). [PDF]
Fukuhara H +11 more
europepmc +1 more source
Fluorescence of Cladophialophora Bantiana After Administration of 5-Aminolevulinic Acid Hydrochloride: Case Report. [PDF]
Mitchell M +3 more
europepmc +1 more source
Redox regulation of glutamate-1-semialdehyde aminotransferase modulates the synthesis of 5-aminolevulinic acid in Arabidopsis. [PDF]
Sinha N +4 more
europepmc +1 more source
5-Aminolevulinic Acid-Mediated Photodynamic Therapy Induces Ferroptosis in Oral Leukoplakia and Oral Squamous Cell Carcinoma. [PDF]
Zhang L, Han Y, Guo Q, Ni X, Liu H.
europepmc +1 more source
Metabolic engineering of <i>Corynebacterium glutamicum</i> for enhanced 5-aminolevulinic acid production via precise porphobilinogen synthase activity modulation. [PDF]
Zhang H +6 more
europepmc +1 more source
Drug-resistant clinical <i>Candida</i> responded to 5-aminolevulinic acid photodynamic therapy (ALA-PDT) <i>in vitro</i> via enhanced ROS release. [PDF]
Yang Z +5 more
europepmc +1 more source

